Document is current
Any future updates will be listed below
-
Authors
Shi, Enxian
Wu, Zhengquan
Karaoglan, Birnur Sinem
Schwenk-Zieger, Sabina
Kranz, Gisela
Abdul Razak, Nilofer
Reichel, Christoph A.
Canis, Martin
Baumeister, Philipp
Zeidler, Reinhard
Gires, Olivier https://orcid.org/0000-0002-2292-7064
-
Funding
Funding for this research was provided by:
Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München (Intramural Funding)
- License Information
-
More Information
Article History
Received: 23 March 2023
Accepted: 18 August 2023
First Online: 24 August 2023
Declarations
:
: Clinical samples were collected upon written informed consent (approval by the Ethikkommission der Medizinischen Fakultät der LMU; #087–03; #197–11; #426–11) in accordance with the WMA Declaration of Helsinki and the Department of Health and Human Services Belmont Report as described [, ].
: Not applicable.
: RZ is an inventor in the patent application 'Novel CD73 antibody, preparation and uses thereof' (PCT/EP2018/063498). All other authors declare that they have no competing interests.
